Meeting
2021 Genitourinary Cancers Symposium
Angiogenic and T-effector subgroups identified by gene expression profiling (GEP) and propensity for PBRM1 and BAP1 alterations in clear cell renal cell carcinoma (ccRCC).
Authors
Pedro C. Barata
Tulane University School of Medicine, New Orleans, LA
Pedro C. Barata , Shuchi Gulati , Andrew Elliott , Arpit Rao , Hans J. Hammers , David I. Quinn , Benjamin Adam Gartrell , Matthew R. Zibelman , Shuanzeng Wei , Daniel M. Geynisman , Tian Zhang , Sourat Darabi , Nancy Ann Dawson , Ralph J. Hauke , Kelsey Anne Poorman , Chadi Nabhan , Charles J. Ryan , Elisabeth I. Heath
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 343)
DOI
10.1200/JCO.2021.39.6_suppl.343
Abstract #
343
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2017 Genitourinary Cancers Symposium
Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
First Author: Jean-Christophe Pignon
Poster
2024 ASCO Genitourinary Cancers Symposium
The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
First Author: Zilin Wang
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai